Prot# WA18062: A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study of the Safety and Reduction of Signs and Symptoms During Treatment with MRA vs. Placebo, in Combination with Methotrexate in Patients with Moderate to Sever

Project: Research project

Project Details

StatusFinished
Effective start/end date9/23/059/11/10

Funding

  • Hoffman-La Roche, Inc. (WA18062)